Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis

Multiple Sclerosis and Related Disorders

Volumn 10, Issue , 2016, Pages 123-126

  Banwell, Emma ^a   Pavisian, Bennis ^a   Lee, Liesly ^a   Feinstein, Anthony ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cannabis; Cannabis use; Multiple sclerosis; Neurology; Psychiatry; Survey

Indexed keywords

CANNABIS;

ADULT; AGE; ANXIETY; ARTICLE; CANADIAN; CANNABIS SMOKING; CANNABIS USE; CONTROLLED STUDY; DEPRESSION; DISABILITY; DISEASE COURSE; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HUMAN; LEGAL ASPECT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PAIN; PATIENT ATTITUDE; QUESTIONNAIRE; SEX DIFFERENCE; SLEEP; SPASTICITY; ATTITUDE TO HEALTH; CANADA; DRUG LEGISLATION; INCIDENCE; PHYTOTHERAPY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

CANADA; CANNABIS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INCIDENCE; LEGISLATION, DRUG; MALE; MARIJUANA SMOKING; MIDDLE AGED; MULTIPLE SCLEROSIS; PHYTOTHERAPY;

EID: 84992034681     PISSN: 22110348     EISSN: 22110356     Source Type: Journal    
DOI: 10.1016/j.msard.2016.09.008     Document Type: Article

References (23)

1. Anderson T., 2001. Drug use and gender. Encycl Criminol Deviant Behav Vol IV Self-Destructive Behav Dis-valued Identity [Internet], pp. 286–289. Available from: 〈 http://www.udel.edu/soc/tammya/pdfs/DrugUseandGender.pdf〉.
2. Center for Behavioral Health Statistics and Quality, 2015. Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. (HHS Pulication No SMA 15-4927, NSDUH Ser H-50 [Internet], 64. Available from: 〈 http://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf/nhttp://www.samhsa.gov/data/〉.
3. Chong, M.S., Wolff, K., Wise, K., Tanton, C., Winstock, A., Silber, E., Cannabis use in patients with multiple sclerosis. Mult. Scler. 12 (2006), 646–651.
4. Clark, A.J., Ware, M.A., Uk, M., Yazer, E., Murray, T.J., Lynch, M.E., Patterns of cannabis use among patients with multiple sclerosis. Neurology 62:11 (2004), 2098–2100.
5. Consroe, P., Musty, R., Rein, J., Tillery, W., Pertwee, R., The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur. Neurol. 38:1 (1997), 44–48.
6. Corey-Bloom, J., Wolfson, T., Gamst, A., Jin, S., Marcotte, T.D., Bentley, H., et al. Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. Can. Med. Assoc. J. 184:10 (2012), 1143–1150.
7. Degenhardt, L., Hall, W., Lynskey, M., The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being. Soc. Psychiatry Psychiatr. Epidemiol. 36:5 (2001), 219–227.
8. Degenhardt, L., Hall, W., Lynskey, M., Exploring the association between cannabis use and depression. Addiction 98:11 (2003), 1493–1504.
9. Federal marijuana legislation to be introduced in spring, 2016 CBC [Internet], Available from: 〈 http://www.cbc.ca/news/politics/philpott-un-marijuana-legislation-legalize-1.3544554〉.
10. Heesen, C., Böhm, J., Reich, C., Kasper, J., Goebel, M., Gold, S.M., Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult. Scler. 14:7 (2008), 988–991.
11. Hohol, M.J., Orav, E.J., Weiner, H.L., Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult. Scler. 5:5 (1999), 349–354.
12. Honarmand, K., Tierney, M.C., O'Connor, P., Feinstein, A., Effects of cannabis on cognitive function in patients with multiple sclerosis. Neurology 76:13 (2011), 1153–1160.
13. Koch-Henriksen, N., Sørensen, P.S., The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 9:5 (2010), 520–532.
14. Koppel, B.S., Brust, J.C.M., Fife, T., Bronstein, J., Youssof, S., Gronseth, G., et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the guideline development subcommittee of the American Academy of Neurology. Neurology [Internet] 82:17 (2014), 1556–1563 (Available from) 〈http://www.ncbi.nlm.nih.gov/pubmed/24778283〉.
15. Martínez-Rodríguez, J.E., Munteis, E., Carreño, M., Blanco, Y., Roquer, J., Abanades, S., et al. Cannabis use in Spanish patients with multiple sclerosis: fulfilment of patients' expectations?. J. Neurol. Sci. 273:1–2 (2008), 103–107.
16. McDonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50:1 (2001), 121–127.
17. Moore, T.H.M., Zammit, S., Lingford-Hughes, A., Barnes, T.R.E., Jones, P.B., Burke, M., et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370:9584 (2007), 319–328.
18. MSIF, 2013. Atlas of MS 2013: mapping multiple sclerosis around the world. Mult. Scler. Int. Fed., pp. 1–28.
19. Page, S.A., Verhoef, M.J., Stebbins, R.A., Metz, L.M., Levy, J.C., Cannabis use as described by people with multiple sclerosis. Can. J. Neurol. Sci. 30:03 (2003), 201–205.
20. Pavisian, B., MacIntosh, B.J., Szilagyi, G., Staines, R.W., O'Connor, P., Feinstein, A., Effects of cannabis on cognition in patients with MS: a psychometric and MRI study. Neurology 82:21 (2014), 1879–1887.
21. ToplineF.JobP.JonesJ.SaadL., 2015. Gallup News Service Gallup Poll Social Series: Economy and Personal Finance. March 2014:2012–2013.
22. Wade, D.T., Makela, P.M., House, H., Bateman, C., Robson, P., Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Mult. Scler. 12:5 (2006), 639–645.
23. Ware, M.A., Wang, T., Shapiro, S., Robinson, A., Ducruet, T., Huynh, T., et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. Can. Med. Assoc. J. 182:14 (2010), E694–E701.